Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Sales (2025)

Historic Return on Sales for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 0.49%.

  • Day One Biopharmaceuticals' Return on Sales fell 8800.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.13%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 1.56% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Return on Sales of 0.49% as of Q3 2025, which was down 8800.0% from 0.89% recorded in Q2 2025.
  • In the past 5 years, Day One Biopharmaceuticals' Return on Sales ranged from a high of 0.38% in Q3 2024 and a low of 13.72% during Q2 2024